Race to Erase MS
Jordan Cohen is a seasoned finance professional with extensive experience in investment banking and corporate operations. As a Partner at Farvahar Partners since May 2020, Jordan advises high-growth venture-backed businesses in various capital formation transactions. Currently serving as the Chief Operating Officer at both 1789 Capital and Colombier Acquisition Corp., Jordan has played a pivotal role in the operations of significant special purpose acquisition companies, including CLBR I and CLBR II. Additionally, Jordan's previous positions include President and Board Member at Ceres Acquisition Corp., Founder & CEO of Playlist Yoga, and Managing Partner at Sierra Bonita Holdings, demonstrating a strong focus on investments and strategic growth in various sectors. Jordan's educational background includes a Juris Doctor from Emory University School of Law and a Bachelor of Science in Accounting and Finance from Tulane University.
This person is not in any teams
This person is not in any offices
Race to Erase MS
Race to Erase MS is dedicated to the treatment and ultimate cure of MS. Funding research is the core focus of the Foundation and all funds raised support our Center Without Walls program, a selected network of the nation’s top MS research centers. This nationwide collaboration of physicians and scientists are on the cutting-edge of innovative research programs, working as a team on therapeutic approaches to eradicate MS. In addition to combating MS through research in a clinical environment, we hope to increase awareness by educating the public about this mystifying disease. Since 1994, the Race to Erase MS has raised over $51 million in contributions. Over the last 27 years, the Race to Erase MS has raised $51,424,622 in contributions. We have funded MS research grants and programs totaling $30,024,009. Since 1999, 72% percent of all Race to Erase MS funds have been spent on program activities, funding cutting edge research through our Center without Walls program, which is greater than the 65% benchmark recommended by the Better Business Bureau Wise Giving Alliance. We are proud of the tremendous strides that have been made in our Race to Erase MS and the advances that have been made towards finding a cure.